date,title,source
Oct-23-18,Xeris Pharmaceuticals Announces FDA Acceptance for Review of NDA for Its Ready-to-Use Glucagon Rescue Pen,Business Wire
Nov-07-18,Xeris Pharmaceuticals Announces Third Quarter 2018 Financial Results and Highlights Pipeline Progress,GlobeNewswire
Dec-20-18,European Medicines Agency Grants Orphan Drug Designation for Xeris Investigational Ready-to-Use Glucagon for the Treatment of Non-Insulinoma Pancreatogenous Hypoglycaemia Syndrome (NIPHS),Business Wire
Feb-11-19,Xeris Pharmaceuticals Announces Proposed Public Offering of Shares of Common Stock,GlobeNewswire
